Orally-bioavailable nucleoside analogs
Described herein are orally-bioavailable nucleoside analogs and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of coronavirus infections, including SARS-CoV-2 infection.
Saved in:
| Format | Patent |
|---|---|
| Language | English |
| Published |
02.05.2023
|
| Online Access | Get full text |
Cover
Loading…
| Summary: | Described herein are orally-bioavailable nucleoside analogs and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of coronavirus infections, including SARS-CoV-2 infection. |
|---|